Madrigal Pharmaceuticals, Inc. (MDGL)
427.18
+1.97
(+0.46%)
USD |
NASDAQ |
Nov 13, 16:00
427.18
0.00 (0.00%)
After-Hours: 19:59
Madrigal Pharmaceuticals Price : 427.18 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 434.48 | 434.48 | 423.19 | 425.21 | 391331.0 |
| Nov 11, 2026 | 433.56 | 440.21 | 431.54 | 433.03 | 296900.0 |
| Nov 10, 2026 | 428.43 | 443.30 | 424.02 | 432.60 | 459039.0 |
| Nov 09, 2026 | 411.50 | 438.74 | 402.00 | 432.79 | 571377.0 |
| Nov 06, 2026 | 400.00 | 401.61 | 378.28 | 399.63 | 1.089M |
| Nov 05, 2026 | 399.60 | 411.95 | 389.32 | 400.10 | 857711.0 |
| Nov 04, 2026 | 398.89 | 402.48 | 353.54 | 400.43 | 2.314M |
| Nov 03, 2026 | 449.32 | 482.72 | 387.33 | 396.32 | 1.979M |
| Nov 02, 2026 | 430.04 | 436.74 | 425.33 | 431.16 | 495143.0 |
| Oct 30, 2026 | 431.55 | 437.80 | 425.00 | 430.36 | 251658.0 |
| Oct 29, 2026 | 434.45 | 445.66 | 427.44 | 431.70 | 268025.0 |
| Oct 28, 2026 | 431.01 | 437.18 | 425.30 | 431.00 | 297529.0 |
| Oct 27, 2026 | 435.79 | 444.83 | 433.89 | 440.33 | 209579.0 |
| Oct 26, 2026 | 435.66 | 443.60 | 432.12 | 437.74 | 275872.0 |
| Oct 23, 2026 | 453.55 | 453.55 | 433.31 | 434.24 | 234853.0 |
| Oct 22, 2026 | 458.11 | 462.50 | 452.08 | 453.34 | 212688.0 |
| Oct 21, 2026 | 467.90 | 481.87 | 456.65 | 457.96 | 338293.0 |
| Oct 20, 2026 | 449.80 | 470.30 | 448.52 | 467.54 | 407976.0 |
| Oct 19, 2026 | 450.64 | 454.50 | 443.48 | 447.09 | 263792.0 |
| Oct 16, 2026 | 459.57 | 462.62 | 446.61 | 449.74 | 364540.0 |
| Oct 15, 2026 | 464.78 | 468.72 | 456.22 | 459.81 | 266191.0 |
| Oct 14, 2026 | 455.52 | 471.50 | 452.29 | 460.01 | 326944.0 |
| Oct 13, 2026 | 467.27 | 468.65 | 448.77 | 452.12 | 315930.0 |
| Oct 12, 2026 | 471.75 | 478.84 | 460.22 | 467.16 | 469271.0 |
| Oct 09, 2026 | 477.48 | 483.64 | 470.53 | 471.75 | 312998.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Insmed, Inc. | 121.16 |
| Alnylam Pharmaceuticals, Inc. | 165.03 |
| Arrowhead Pharmaceuticals, Inc. | 47.76 |
| Cytokinetics, Inc. | 56.07 |
| United Therapeutics Corp. | 591.11 |
Price Related Metrics
| PS Ratio | 8.326 |
| Price to Book Value | 15.82 |
| Earnings Yield | -1.40% |
| Market Cap | 9.920B |